Teleflex Incorporated (TFX) To Go Ex-Dividend on March 6th

Teleflex Incorporated (NYSE:TFX) declared a quarterly dividend on Tuesday, February 24th. Shareholders of record on Friday, March 6th will be paid a dividend of 0.34 per share by the medical technology company on Tuesday, March 31st. This represents a c) dividend on an annualized basis and a yield of 1.1%. The ex-dividend date is Friday, March 6th.

Teleflex has a dividend payout ratio of 9.7% meaning its dividend is sufficiently covered by earnings. Research analysts expect Teleflex to earn $15.18 per share next year, which means the company should continue to be able to cover its $1.36 annual dividend with an expected future payout ratio of 9.0%.

Teleflex Price Performance

Shares of Teleflex stock opened at $122.02 on Wednesday. The company has a debt-to-equity ratio of 0.81, a quick ratio of 2.01 and a current ratio of 2.54. Teleflex has a 52-week low of $100.18 and a 52-week high of $143.32. The company has a fifty day moving average of $111.31 and a 200-day moving average of $118.70. The stock has a market capitalization of $5.39 billion, a price-to-earnings ratio of -5.94, a price-to-earnings-growth ratio of 0.76 and a beta of 0.87.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, February 26th. The medical technology company reported $1.93 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.73 by ($1.80). Teleflex had a negative net margin of 30.56% and a positive return on equity of 14.30%. The company had revenue of $569.00 million for the quarter, compared to the consensus estimate of $912.57 million. During the same period last year, the business posted $3.89 earnings per share. The firm’s quarterly revenue was down 28.5% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Equities research analysts expect that Teleflex will post 13.98 EPS for the current year.

Institutional Trading of Teleflex

Institutional investors and hedge funds have recently bought and sold shares of the stock. Josh Arnold Investment Consultant LLC purchased a new stake in Teleflex in the 4th quarter worth $32,341,000. Invesco Ltd. lifted its position in shares of Teleflex by 3.0% in the fourth quarter. Invesco Ltd. now owns 162,882 shares of the medical technology company’s stock worth $19,878,000 after buying an additional 4,807 shares in the last quarter. Alberta Investment Management Corp bought a new position in Teleflex during the fourth quarter valued at approximately $1,318,000. Vident Advisory LLC grew its holdings in Teleflex by 2.8% during the 4th quarter. Vident Advisory LLC now owns 6,992 shares of the medical technology company’s stock valued at $853,000 after buying an additional 188 shares in the last quarter. Finally, State of Tennessee Department of Treasury boosted its position in shares of Teleflex by 4.7% during the 4th quarter. State of Tennessee Department of Treasury now owns 22,374 shares of the medical technology company’s stock valued at $2,731,000 after acquiring an additional 998 shares during the last quarter. 95.62% of the stock is currently owned by institutional investors.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.